If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Michele Cilli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Combined Replenishment of miR-34a and let-7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical Models

Di Paolo, D., Pastorino, F., Brignole, C., Corrias, M. V., Emionite, L., Cilli, M., Tamma, R., Priddy, L., Amaro, A., Ferrari, D., Marotta, R., Ferretti, E., Pfeffer, U., Ribatti, D., Sementa, A. R., Brown, D., Ikegaki, N., Shimada, H., Ponzoni, M. & Perri, P., Jan 1 2020, (Accepted/In press) In : Small.

Research output: Contribution to journalArticle

  • Fibrin gels entrapment of a doxorubicin-containing targeted polycyclodextrin: Evaluation of in vivo antitumor activity in orthotopic models of human neuroblastoma

    Viale, M., Vecchio, G., Maric, I., Cilli, M., Aprile, A., Ponzoni, M., Fontana, V., Priori, E. C., Bertone, V. & Rocco, M., Dec 15 2019, In : Toxicology and Applied Pharmacology. 385, 114811.

    Research output: Contribution to journalArticle

  • Fibrin Gels Entrapment of a Poly-Cyclodextrin Nanocarrier as a Doxorubicin Delivery System in an Orthotopic Model of Neuroblastoma: Evaluation of In Vitro Activity and In Vivo Toxicity

    Viale, M., Vecchio, G., Monticone, M., Bertone, V., Giglio, V., Maric, I., Cilli, M., Bocchini, V., Profumo, A., Ponzoni, M., Emionite, L. & Rocco, M., Aug 1 2019, In : Pharmaceutical Research. 36, 8, 115.

    Research output: Contribution to journalArticle

  • LncRNA EPR controls epithelial proliferation by coordinating Cdkn1a transcription and mRNA decay response to TGF-β

    Rossi, M., Bucci, G., Rizzotto, D., Bordo, D., Marzi, M. J., Puppo, M., Flinois, A., Spadaro, D., Citi, S., Emionite, L., Cilli, M., Nicassio, F., Inga, A., Briata, P. & Gherzi, R., Dec 1 2019, In : Nature Communications. 10, 1, 1969.

    Research output: Contribution to journalArticle

    Open Access
  • A high-content screening of anticancer compounds suggests the multiple tyrosine kinase inhibitor ponatinib for repurposing in neuroblastoma therapy

    Sidarovich, V., De Mariano, M., Aveic, S., Pancher, M., Adami, V., Gatto, P., Pizzini, S., Pasini, L., Croce, M., Parodi, F., Cimmino, F., Avitabile, M., Emionite, L., Cilli, M., Ferrini, S., Pagano, A., Capasso, M., Quattrone, A., Tonini, G. P. & Longo, L., Jul 1 2018, In : Molecular Cancer Therapeutics. 17, 7, p. 1405-1415 11 p.

    Research output: Contribution to journalArticle